questionsmedicales.fr
Acides nucléiques, nucléotides et nucléosides
Acides nucléiques
ARN
ARN ribosomique
ARN ribosomique 18S
ARN ribosomique 18S : Questions médicales fréquentes
Termes MeSH sélectionnés :
Borderline Personality Disorder
Diagnostic
5
ARN ribosomique
PCR
Séquençage
Électrophorèse
Hybridation
Qualité de l'ARN
Spécificité des espèces
Identification
Variabilité génétique
RT-qPCR
Quantification
Expression génique
Échantillons biologiques
Tissus
Cellules
Symptômes
5
Troubles de croissance
Maladies génétiques
Anomalies génétiques
Santé cellulaire
Synthèse protéique
Perturbation cellulaire
Infections
Expression de l'ARN
Réponse immunitaire
Cancer
Niveaux d'ARN
Oncologie
Maladies neurodégénératives
Études
ARN ribosomique
Prévention
5
Prévention
Nutrition
Mode de vie sain
Éducation génétique
Prévention
Risques
Dépistage
Anomalies génétiques
Identification précoce
Vaccinations
Immunité
Expression de l'ARN
Alimentation
Acides gras oméga-3
Antioxydants
Traitements
5
Thérapies géniques
Médicaments
Expression génique
Thérapie
Approches thérapeutiques
Maladies
Antibiotiques
Ribosomes
Synthèse protéique
Anomalies de l'ARN
Traitements spécifiques
Développement thérapeutique
Thérapies ciblées
Modulation
Pathologies
Complications
5
Complications
Troubles métaboliques
Maladies héréditaires
Complications respiratoires
Infections
Études
Complications neurologiques
Troubles neurologiques
Anomalies
Complications cancéreuses
Niveaux d'ARN
Types de cancers
Complications métaboliques
Déséquilibres
Syndromes
Facteurs de risque
5
Facteurs de risque
Génétique
Environnement
Toxines
Altération
Dommages
Stress oxydatif
Stabilité
Expression de l'ARN
Habitudes alimentaires
Déséquilibre
Santé cellulaire
Âge
Facteurs de risque
Modifications
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "ARN ribosomique 18S : Questions médicales les plus fréquentes",
"headline": "ARN ribosomique 18S : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les ARN ribosomique 18S : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2025-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "ARN ribosomique 18S"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "ARN ribosomique",
"url": "https://questionsmedicales.fr/mesh/D012335",
"about": {
"@type": "MedicalCondition",
"name": "ARN ribosomique",
"code": {
"@type": "MedicalCode",
"code": "D012335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.444.735.686"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "ARN ribosomique 18S",
"alternateName": "RNA, Ribosomal, 18S",
"code": {
"@type": "MedicalCode",
"code": "D012337",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harutaro Kenmotsu",
"url": "https://questionsmedicales.fr/author/Harutaro%20Kenmotsu",
"affiliation": {
"@type": "Organization",
"name": "Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan."
}
},
{
"@type": "Person",
"name": "Yuu Hirose",
"url": "https://questionsmedicales.fr/author/Yuu%20Hirose",
"affiliation": {
"@type": "Organization",
"name": "Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan."
}
},
{
"@type": "Person",
"name": "Toshihiko Eki",
"url": "https://questionsmedicales.fr/author/Toshihiko%20Eki",
"affiliation": {
"@type": "Organization",
"name": "Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan."
}
},
{
"@type": "Person",
"name": "Ludivine Wacheul",
"url": "https://questionsmedicales.fr/author/Ludivine%20Wacheul",
"affiliation": {
"@type": "Organization",
"name": "RNA Molecular Biology, ULB Cancer Research Center (U-CRC), Centre for Microscopy and Molecular Imaging (CMMI), Fonds de la Recherche Scientifique (F.R.S.-FNRS), Université Libre de Bruxelles (ULB), Charleroi-Gosselies, Belgium."
}
},
{
"@type": "Person",
"name": "Anil Kumar Nehra",
"url": "https://questionsmedicales.fr/author/Anil%20Kumar%20Nehra",
"affiliation": {
"@type": "Organization",
"name": "Department of Veterinary Parasitology, Lala Lajpat Rai University of Veterinary and Animal Sciences, 125004, Hisar, Haryana, India. anilnehra15@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review.",
"datePublished": "2022-05-16",
"url": "https://questionsmedicales.fr/article/35575169",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/bsl.2576"
}
},
{
"@type": "ScholarlyArticle",
"name": "Personal Identity and Narrativity in Borderline Personality Disorder: A Phenomenological Reconfiguration.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36137507",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000526222"
}
},
{
"@type": "ScholarlyArticle",
"name": "Personal agency and borderline personality disorder: a longitudinal study of outcomes.",
"datePublished": "2022-08-22",
"url": "https://questionsmedicales.fr/article/35996102",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12888-022-04214-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Hopelessness in Patients With Borderline Personality Disorder.",
"datePublished": "2024-09-01",
"url": "https://questionsmedicales.fr/article/39357013",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PRA.0000000000000813"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacological interventions for people with borderline personality disorder.",
"datePublished": "2022-11-14",
"url": "https://questionsmedicales.fr/article/36375174",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD012956.pub2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides nucléiques",
"item": "https://questionsmedicales.fr/mesh/D009696"
},
{
"@type": "ListItem",
"position": 4,
"name": "ARN",
"item": "https://questionsmedicales.fr/mesh/D012313"
},
{
"@type": "ListItem",
"position": 5,
"name": "ARN ribosomique",
"item": "https://questionsmedicales.fr/mesh/D012335"
},
{
"@type": "ListItem",
"position": 6,
"name": "ARN ribosomique 18S",
"item": "https://questionsmedicales.fr/mesh/D012337"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : ARN ribosomique 18S - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur ARN ribosomique 18S",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur ARN ribosomique 18S",
"description": "Comment détecte-t-on l'ARN ribosomique 18S ?\nQuels tests sont utilisés pour l'analyse de l'ARN 18S ?\nL'ARN 18S est-il spécifique à certaines espèces ?\nPeut-on quantifier l'ARN 18S ?\nQuels échantillons sont nécessaires pour l'analyse de l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Borderline+Personality+Disorder#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur ARN ribosomique 18S",
"description": "Quels symptômes sont liés à des anomalies de l'ARN 18S ?\nL'ARN 18S affecte-t-il la santé cellulaire ?\nDes infections peuvent-elles influencer l'ARN 18S ?\nY a-t-il des signes de cancer liés à l'ARN 18S ?\nL'ARN 18S est-il impliqué dans des maladies neurodégénératives ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Borderline+Personality+Disorder#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur ARN ribosomique 18S",
"description": "Comment prévenir les anomalies de l'ARN 18S ?\nL'éducation génétique peut-elle aider à prévenir des maladies liées à l'ARN 18S ?\nDes dépistages réguliers sont-ils recommandés ?\nLes vaccinations influencent-elles l'ARN 18S ?\nY a-t-il des recommandations alimentaires pour la santé de l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Borderline+Personality+Disorder#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur ARN ribosomique 18S",
"description": "Quels traitements ciblent l'ARN 18S ?\nL'ARN 18S peut-il être utilisé en thérapie ?\nComment les antibiotiques affectent-ils l'ARN 18S ?\nY a-t-il des traitements pour les anomalies de l'ARN 18S ?\nLes thérapies ciblées peuvent-elles influencer l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Borderline+Personality+Disorder#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur ARN ribosomique 18S",
"description": "Quelles complications peuvent survenir avec des anomalies de l'ARN 18S ?\nL'ARN 18S est-il lié à des complications respiratoires ?\nDes complications neurologiques peuvent-elles être liées à l'ARN 18S ?\nL'ARN 18S peut-il être impliqué dans des complications cancéreuses ?\nQuelles sont les complications métaboliques liées à l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Borderline+Personality+Disorder#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur ARN ribosomique 18S",
"description": "Quels facteurs de risque sont associés à des anomalies de l'ARN 18S ?\nL'exposition à des toxines affecte-t-elle l'ARN 18S ?\nLe stress oxydatif influence-t-il l'ARN 18S ?\nDes habitudes alimentaires peuvent-elles influencer l'ARN 18S ?\nL'âge est-il un facteur de risque pour l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Borderline+Personality+Disorder#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on l'ARN ribosomique 18S ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ARN 18S est souvent détecté par PCR ou séquençage pour identifier des organismes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'analyse de l'ARN 18S ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse et l'hybridation pour évaluer la qualité de l'ARN."
}
},
{
"@type": "Question",
"name": "L'ARN 18S est-il spécifique à certaines espèces ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'ARN 18S présente des variations spécifiques aux espèces, utile pour l'identification."
}
},
{
"@type": "Question",
"name": "Peut-on quantifier l'ARN 18S ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la quantification se fait par RT-qPCR pour mesurer l'expression génique."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont nécessaires pour l'analyse de l'ARN 18S ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de tissus, cellules ou fluides biologiques sont requis pour l'analyse."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des anomalies de l'ARN 18S ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies peuvent entraîner des troubles de croissance ou des maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'ARN 18S affecte-t-il la santé cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux d'ARN 18S peuvent perturber la synthèse protéique et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Des infections peuvent-elles influencer l'ARN 18S ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent altérer l'expression de l'ARN 18S, affectant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de cancer liés à l'ARN 18S ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux d'ARN 18S modifiés peuvent être associés à certains types de cancer."
}
},
{
"@type": "Question",
"name": "L'ARN 18S est-il impliqué dans des maladies neurodégénératives ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre l'ARN 18S et certaines maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies de l'ARN 18S ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition et un mode de vie sain peuvent aider à prévenir les anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation génétique peut-elle aider à prévenir des maladies liées à l'ARN 18S ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation génétique permet de mieux comprendre les risques et de prendre des mesures préventives."
}
},
{
"@type": "Question",
"name": "Des dépistages réguliers sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent aider à identifier précocement des anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles l'ARN 18S ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations peuvent indirectement influencer l'expression de l'ARN 18S en renforçant l'immunité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires pour la santé de l'ARN 18S ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en acides gras oméga-3 et en antioxydants peut soutenir la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'ARN 18S ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des médicaments peuvent cibler l'expression de l'ARN 18S."
}
},
{
"@type": "Question",
"name": "L'ARN 18S peut-il être utilisé en thérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches thérapeutiques exploitent l'ARN 18S pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment les antibiotiques affectent-ils l'ARN 18S ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antibiotiques ciblent les ribosomes, affectant ainsi l'ARN 18S et la synthèse protéique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements pour les anomalies de l'ARN 18S ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements spécifiques peuvent être développés pour corriger les anomalies de l'ARN 18S."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées peuvent-elles influencer l'ARN 18S ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies ciblées peuvent moduler l'expression de l'ARN 18S dans certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies de l'ARN 18S ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques et des maladies héréditaires."
}
},
{
"@type": "Question",
"name": "L'ARN 18S est-il lié à des complications respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent un lien potentiel entre l'ARN 18S et certaines infections respiratoires."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques peuvent-elles être liées à l'ARN 18S ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de l'ARN 18S peuvent être associées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'ARN 18S peut-il être impliqué dans des complications cancéreuses ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux d'ARN 18S sont souvent observés dans divers types de cancers."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications métaboliques liées à l'ARN 18S ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de l'ARN 18S peuvent entraîner des déséquilibres métaboliques et des syndromes."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à des anomalies de l'ARN 18S ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et nutritionnels peuvent influencer l'ARN 18S."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle l'ARN 18S ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut altérer l'expression de l'ARN 18S et causer des dommages."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif influence-t-il l'ARN 18S ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut affecter la stabilité et l'expression de l'ARN 18S."
}
},
{
"@type": "Question",
"name": "Des habitudes alimentaires peuvent-elles influencer l'ARN 18S ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affecter l'expression de l'ARN 18S et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour l'ARN 18S ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner des modifications de l'expression de l'ARN 18S."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan.
Publications dans "ARN ribosomique 18S" :
3 publications dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan.
Research Center for Agrotechnology and Biotechnology, Toyohashi University of Technology, Toyohashi, Aichi, Japan.
Publications dans "ARN ribosomique 18S" :
3 publications dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan.
Research Center for Agrotechnology and Biotechnology, Toyohashi University of Technology, Toyohashi, Aichi, Japan.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
RNA Molecular Biology, ULB Cancer Research Center (U-CRC), Centre for Microscopy and Molecular Imaging (CMMI), Fonds de la Recherche Scientifique (F.R.S.-FNRS), Université Libre de Bruxelles (ULB), Charleroi-Gosselies, Belgium.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Parasitology, Lala Lajpat Rai University of Veterinary and Animal Sciences, 125004, Hisar, Haryana, India. anilnehra15@gmail.com.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Medicine, Lala Lajpat Rai University of Veterinary and Animal Sciences, 125004, Hisar, Haryana, India.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Parasitology, Lala Lajpat Rai University of Veterinary and Animal Sciences, 125004, Hisar, Haryana, India.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Genomics Group, Nord University, Bodø, Norway.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Core Unit Systems Medicine, Institute for Molecular Infection Biology, University of Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA.
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, CA 94720, USA.
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Gene Center, Department of Biochemistry and Center for integrated Protein Science Munich (CiPSM), Ludwig-Maximilians-Universität München, Feodor-Lynen-Strasse 25, 81377 Munich, Germany.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Gene Center, Department of Biochemistry and Center for integrated Protein Science Munich (CiPSM), Ludwig-Maximilians-Universität München, Feodor-Lynen-Strasse 25, 81377 Munich, Germany. Electronic address: beckmann@genzentrum.lmu.de.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Biology and Biochemistry, University of Houston, Houston, Texas 77204-5001, USA.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Biology and Biochemistry, University of Houston, Houston, Texas 77204-5001, USA fox@uh.edu.
Publications dans "ARN ribosomique 18S" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: ragreen@jhmi.edu.
Publications dans "ARN ribosomique 18S" :
1 publication dans cette catégorie
Affiliations :
Institute of Molecular Biology (IMB), Mainz, Germany.
Publications dans "ARN ribosomique 18S" :
1 publication dans cette catégorie
Affiliations :
Institute of Molecular Biology (IMB), Mainz, Germany.
Publications dans "ARN ribosomique 18S" :
Individuals with borderline personality disorder (BPD) or antisocial personality disorder (ASPD) are overrepresented in forensic settings. Yet, despite the burden these disorders place on healthcare a...
Borderline personality disorder (BPD) is a complex condition marked by heterogeneity. People with BPD have a profusion of symptoms spread across various levels of lived experience, such as identity, a...
Low personal agency is the concept of attributing successes and failures to external factors rather than personal characteristics. Previous research supported links between low personal agency and sym...
Patients (N = 57, age 18-72, 91.5% female) were assessed at intake, after three months of DBT treatment, and 12 months follow up on measures of symptoms and personal agency. Three separate measures we...
Mixed model analyses found BPD symptoms significantly reduced as a result of DBT treatment and were maintained at follow-up. However, 47% of participants continued to meet BPD criteria 12 months later...
Despite the reductions in BPD symptomology, personal agency did not significantly change over time. Those with lower agency at intake continued to do more poorly at follow up. We speculate that poor o...
The goal of this study was to evaluate specific characteristics associated with hopelessness, potentially correlated with coping strategies, sensory profile, and alexithymia in patients with borderlin...
Two hundred twenty-four (N=224) inpatients completed a clinical interview with administration of the Beck Hopelessness Scale (BHS), the Adolescent/Adult Sensory Profile (AASP), the Coping Orientation ...
Hopelessness was significantly associated with female gender, more hospitalizations, current suicidal ideation, number of suicide attempts, current and lifetime medication abuse, and alcohol misuse. F...
Hopelessness in BPD was associated with higher severity of illness, alternative process sensory input from the environment, reduced ability to cope with stressful events, and alexithymia. Therefore, a...
Among people with a diagnosis of borderline personality disorder (BPD) who are engaged in clinical care, prescription rates of psychotropic medications are high, despite the fact that medication use i...
To assess the effects of pharmacological treatment for people with BPD....
For this update, we searched CENTRAL, MEDLINE, Embase, 14 other databases and four trials registers up to February 2022. We contacted researchers working in the field to ask for additional data from p...
Randomised controlled trials comparing pharmacological treatment to placebo, other pharmacologic treatments or a combination of pharmacologic treatments in people of all ages with a formal diagnosis o...
At least two review authors independently selected trials, extracted data, assessed risk of bias using Cochrane's risk of bias tool and assessed the certainty of the evidence using the GRADE approach....
We included 46 randomised controlled trials (2769 participants) in this review, 45 of which were eligible for quantitative analysis and comprised 2752 participants with BPD in total. This is 18 more t...
This review included 18 more trials than the 2010 version, so larger meta-analyses with more statistical power were feasible. We found mostly very low-certainty evidence that medication may result in ...
People diagnosed with borderline personality disorder (BPD) frequently present to healthcare services in crisis, often with suicidal thoughts or actions. Despite this, little is known about what const...
To assess the effects of crisis interventions in adults diagnosed with BPD in any setting....
We searched CENTRAL, MEDLINE, Embase, nine other databases and three trials registers up to January 2022. We also checked reference lists, handsearched relevant journal archives and contacted experts ...
Randomised controlled trials (RCTs) comparing crisis interventions with usual care, no intervention or waiting list, in adults of any age diagnosed with BPD....
We used standard methodological procedures expected by Cochrane....
We included two studies with 213 participants. One study (88 participants) was a feasibility RCT conducted in the UK that examined the effects of joint crisis plans (JCPs) plus treatment as usual (TAU...
A comprehensive search of the literature revealed very little RCT-based evidence to inform the management of acute crises in people diagnosed with BPD. We included two studies of two very different ty...
The progressively improving understanding of the borderline personality disorder (BPD) has led to an increased interest in the better clarification of the integrated role of biological and psychosocia...
Previous research has emphasized the importance of therapists giving Routine Outcome Monitoring (ROM) feedback to their patients. It has been shown that several factors influence therapists' tendency ...
In this qualitative study, using a semi-structured interview followed by thematic analysis using Atlas.ti, we focused on experiences of therapists and patients with a disorder specific ROM instrument:...
Qualitative analysis revealed that patients experienced benefits of ROM using the BPDSI-IV. Patients gained more insight in and recognition of their borderline personality disorder symptoms. They also...
Experiences of both patients and therapists with the BPDSI-IV were positive. It seems to be valuable and promising for healthcare institutions to evaluate treatment with a disorder specific ROM instru...
It has been suggested that the diagnosis of borderline personality disorder (BPD) is associated with particularly stigmatizing connotations, particularly among mental health professionals. The goal of...
A systematic search was carried out using MEDLINE Complete, CINAHL Complete, PsychoINFO, PsychARTICLES, Scopus, Social Sciences Citation Index, and Academic Search Complete. Study quality was rated us...
This review included 37 papers involving an estimated 8196 participants: 21 cross-sectional survey studies, 5 studies assessing training workshops, 5 studies assessing countertransference, and 6 exper...
Negative attitudes toward BPD continue to be a problem to differing degrees among clinical staff. Although this issue is most prominent among psychiatric nurses, the results of this review highlight e...
Comorbidity between borderline personality disorder (BPD) and other mental disorders is common. Although no specific pharmacological treatments have been approved for the treatment of BPD, many drugs,...